Need professional-grade analysis? Visit stockanalysis.com
$32.94M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Genetic Signatures Ltd (GSS) Price Performance
Genetic Signatures Ltd (GSS) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at AUD0.14, down 3.33% from the previous close.
Over the past year, GSS has traded between a low of AUD0.07 and a high of AUD0.68. The stock has lost 67.0% over this period. It is currently 78.5% below its 52-week high.
Genetic Signatures Ltd has a market capitalization of $32.94M.
About Genetic Signatures Ltd
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. It offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. The company was incorporated in 2001 and is headquartered in Newtown, Australia.
Compare Genetic Signatures Ltd
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- Australian Securities Exchange
- Currency
- AUD
- Country
- Australia
Financial Metrics
- Revenue (TTM)
- $19.93M
- EBITDA
- $-10,420,000
- Profit Margin
- -56.53%
- EPS (TTM)
- -0.05
- Book Value
- 0.19
Technical Indicators
- 52 Week High
- A$0.69
- 52 Week Low
- A$0.07
- 50 Day MA
- A$0.10
- 200 Day MA
- A$0.23
- Beta
- 0.52
Valuation
- Trailing P/E
- N/A
- Forward P/E
- 52.36
- Price/Sales
- 1.65
- Price/Book
- 0.77
- Enterprise Value
- $4.76M